Clin2
NCT07230496Possibly a fitRecruiting

Safety study of an investigational weight-management drug

Overweight and Obesity

Part of Hormones & metabolism clinical trials.

This study is testing a new investigational drug, either alone or combined with another drug, to see how safe it is and how the body processes it. It is for healthy people who are overweight or obese, and results may help in developing future treatments for weight management.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
104 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are aged 18 to 55 (or 45 to 75 for a specific part of the study).
  • Your body mass index (BMI) is between 25 and 40.
  • You are generally healthy, with no major medical conditions like diabetes or heart disease.
  • You have not used weight-loss medications in the last 3 months.
  • You are willing to avoid alcohol and heavy smoking during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07857473Not yet recruiting· Phase 2
Weight loss study for overweight or obese adults

This study tests an investigational drug called TE-8105 to see if it is safe and effective for helping adults who are overweight or obese lose weight. It may be an option for you if you are looking for a medical approach to weight management.

Leichhardt, New South Wales
NCT06493084Recruiting· Phase 1
Testing LAE102 in healthy and overweight adults

This study tests a new medicine called LAE102 in two groups: healthy volunteers and people who are overweight or obese. The goal is to see if it is safe and how the body processes it.

Shanghai, Shanghai Municipality
NCT07826364Not yet recruiting· Phase 1
Testing a new obesity treatment for safety and weight loss

This trial tests a new injectable medication called SHR-1179 to see if it is safe and can help with weight loss. It is a placebo-controlled study, meaning some participants receive the drug and others receive an inactive shot, and no one knows which they get.

Shanghai, Shanghai Municipality
NCT07824804Not yet recruiting· Phase 1
Safety study of an injection for weight management

This study tests a new injection (MWN117) in healthy people and in people with obesity. It aims to see if the drug is safe and how the body handles it, which may eventually help with weight management.

Kunming, Yunnan
NCT07716241Not yet recruiting· Phase 1
Study of an investigational injection for weight management in healthy or overweight adults

This study tests a new injected medicine (called HS-20136-2) to see if it is safe and how the body handles it. It is an early (phase 1) trial that includes healthy people and people with overweight, and the goal is to learn about possible effects on weight and metabolism.

Hefei
NCT07467447Recruiting· Phase 2
Testing a weight-loss drug for people with obesity or overweight

This trial tests whether an experimental drug (LY3437943) can help people with obesity or overweight lose weight. It compares the drug to a placebo (inactive shot), and you must be willing to give yourself daily injections.

Shenzhen, Guangdong

Hear when a new Overweight and Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.